SCLDSCCL
UTHR icon

Split Creek LLC DBA Split Creek Capital LLC’s United Therapeutics UTHR Stock Holding History

Split Creek LLC DBA Split Creek Capital LLC’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-426
Closed -$253K – 145
2026
Q1 		$253K Sell
426
-58
-12% -$28.9K 0.27% 105
2025
Q4 		$236K Buy
+484
New +$225K 0.25% 118

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Split Creek LLC DBA Split Creek Capital LLC's UTHR Position: Q2 2026 in Review

Split Creek LLC DBA Split Creek Capital LLC sold out of United Therapeutics (UTHR) in Q2 2026, closing a stake of 426 shares — an estimated $253K sold.

Split Creek LLC DBA Split Creek Capital LLC first reported a position in UTHR in Q4 2025 and held it in 2 quarters. The position peaked at $253K in Q1 2026. 885 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Split Creek LLC DBA Split Creek Capital LLC reported no remaining United Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Split Creek LLC DBA Split Creek Capital LLC sold 426 United Therapeutics shares in Q2 2026, an estimated $253K.
  • Split Creek LLC DBA Split Creek Capital LLC first reported a position in United Therapeutics in Q4 2025 and held it in 2 quarters.
  • Split Creek LLC DBA Split Creek Capital LLC's United Therapeutics position peaked at $253K in Q1 2026.
  • 885 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Split Creek LLC DBA Split Creek Capital LLC's 13F filing for Q2 2026, filed 23 Oct 2026.